Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for CytRx Corporation (CYTR)

« Back to company index

CYTR Chatter Timeline

Stock Ticker for CYTR

Most Active Tweeters for CYTR

UserTweets
@RTFilingsStocks 1
@Allstocknews 1
@fintel_io 1
@LifeSciGuy 1
@WKRBNews 1

Recent Tweets for CYTR

WKRBNews @WKRBNews
Allogene Therapeutics $ALLO and CytRx $CYTR Head to Head Comparison https://t.co/BB3BgCapiO #markets
June 12th 2019, 4:06am
LifeSciGuy @LifeSciGuy
$CYTR announces NASDAQ delisting and trading on OTCQB on June 4. Patrick Soon-Shiong announces he is "launching" I… https://t.co/u9vcPdsVVm
June 6th 2019, 5:06pm
fintel_io @fintel_io
Soon-shiong Patrick has filed a new 13G, reporting 5.9% ownership in $CYTR - https://t.co/2zbsKJXQiP
June 6th 2019, 4:06pm
Allstocknews @Allstocknews
$CYTR New Form SC 13G for CytRx Corporation From our Stock News Alerts App
June 6th 2019, 4:06pm
RTFilingsStocks @RTFilingsStocks
SOON-SHIONG PATRICK files 13G disclosing 5.9% stake in $CYTR https://t.co/39vuL2vyzu
June 6th 2019, 4:06pm
dakotafinancial @dakotafinancial
-$0.06 Earnings Per Share Expected for CytRx Co. $CYTR This Quarter https://t.co/p23F7D965Q
June 4th 2019, 7:06am
SwingTradeBot @SwingTradeBot
New 52 Week Low today: $CYTR $NAVB ... https://t.co/0EM4q8YtyQ
June 3rd 2019, 2:06pm
AmericanBanking @AmericanBanking
Analysts Expect CytRx Co. $CYTR Will Post Earnings of -$0.06 Per Share https://t.co/aJuI2rz9Bh #stocks
June 1st 2019, 10:06am
TraderTexMex @TraderTexMex
$CYTR Your run is over! Going to the OTC markets next week. Cya!!
May 31st 2019, 10:05am
fintel_io @fintel_io
Also, if you are new to $CYTR here's some background for you https://t.co/1LmPul5HQa
May 31st 2019, 9:05am
fintel_io @fintel_io
$CYTR / CytRx files form 8-K https://t.co/KgrX7qzK46 - Notice of Delisting or Failure to Satisfy a Continued Listin… https://t.co/7YZZyALWTE
May 31st 2019, 9:05am
Allstocknews @Allstocknews
$CYTR New Form 8-K for CytRx Corporation From our Stock News Alerts App
May 31st 2019, 9:05am
StockWatchHQ @StockWatchHQ
RT @FlyOnTheWallHQ: All Hands On Deck_Swiss Meetings To Continue In Basel As Roche And CytRx Corp $CYTR Legal Teams Hammer Out Fair And Equ…
May 31st 2019, 1:05am
FlyOnTheWallHQ @FlyOnTheWallHQ
All Hands On Deck_Swiss Meetings To Continue In Basel As Roche And CytRx Corp $CYTR Legal Teams Hammer Out Fair And… https://t.co/Ou0vSPeJPO
May 30th 2019, 1:05pm
StockWatchHQ @StockWatchHQ
RT @FlyOnTheWallHQ: To The Victor Go The Spoils_Roche and CytRx Corp $CYTR Schedule Meeting In Geneva Mid November https://t.co/hAFEjvavnV…
May 29th 2019, 10:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
To The Victor Go The Spoils_Roche and CytRx Corp $CYTR Schedule Meeting In Geneva Mid November… https://t.co/X5L9Xfh3Iu
May 29th 2019, 1:05pm
StockRatingsHQ @StockRatingsHQ
RT @FlyOnTheWallHQ: Kiss And Tell_CytRx Corporation $CYTR Management Not Yet Commenting On Merck $MRK Offer https://t.co/kDb9GvuBnv Expert…
May 24th 2019, 11:05am
FlyOnTheWallHQ @FlyOnTheWallHQ
Kiss And Tell_CytRx Corporation $CYTR Management Not Yet Commenting On Merck $MRK Offer https://t.co/kDb9GvuBnv Ex… https://t.co/dtc6FmBdIp
May 23rd 2019, 12:05pm
b4uconsent @b4uconsent
Our banned @BuyersStrike posted about spider silk scams wherein it’s revealed that $CYTR is still operating. Check… https://t.co/ZMfpBaDHGI
May 20th 2019, 12:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @StockWatchHQ: CytRx $CYTR To Meet With Celgene $CELG This Week In Summit, NJ As Yet Another Biotech Buyout Looms https://t.co/fI3dpgTwU…
May 19th 2019, 7:05pm
StockWatchHQ @StockWatchHQ
CytRx $CYTR To Meet With Celgene $CELG This Week In Summit, NJ As Yet Another Biotech Buyout Looms… https://t.co/WJi5JpP4ZA
May 18th 2019, 8:05pm
registrarjourn @registrarjourn
CytRx $CYTR Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/NyCCTwdkny
May 16th 2019, 11:05am
EnterpriseLeade @EnterpriseLeade
CytRx $CYTR Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS https://t.co/6jNzelyKUe
May 16th 2019, 11:05am
WKRBNews @WKRBNews
CytRx $CYTR Releases Earnings Results, Beats Expectations By $0.01 EPS https://t.co/eSpDY5jZ3L #markets
May 16th 2019, 10:05am
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: A Deal Is In The Works_CytRx Corp $CYTR Will Announce Terms Of Agreement Reached in New Partnership Deal With Big Pharma…
May 15th 2019, 10:05am
Allstocknews @Allstocknews
$CYTR New Form 10-Q for CytRx Corporation From our Stock News Alerts App
May 15th 2019, 9:05am
StockWatchHQ @StockWatchHQ
A Deal Is In The Works_CytRx Corp $CYTR Will Announce Terms Of Agreement Reached in New Partnership Deal With Big P… https://t.co/4TkWLTPTez
May 14th 2019, 11:05pm
ThisLincolnian @ThisLincolnian
Zacks: Analysts Anticipate CytRx Co. $CYTR to Announce -$0.06 Earnings Per Share https://t.co/8GoK2F508j
May 12th 2019, 8:05am
AmericanBanking @AmericanBanking
Zacks: Brokerages Expect CytRx Co. $CYTR to Post -$0.06 Earnings Per Share https://t.co/PNScb8V7tJ #stocks
May 9th 2019, 8:05am
otc_watch_news @otc_watch_news
$CYTR #null CytRx Corp. (CYTR: null) | CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the T… https://t.co/8HHB4QpfRi
May 8th 2019, 12:05pm
StockNewsNow @StockNewsNow
$CYTR CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain Cancer https://t.co/uYFrw4YCnq
May 8th 2019, 11:05am
ez_alertz @ez_alertz
$CYTR CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain Cancer https://t.co/g3bXeLIKaC
May 8th 2019, 9:05am
susanfoofoo @susanfoofoo
$CYTR :CytRx issued patent covering use of aldoxorubicin for treatment of brain cancer. The new patent issued on M… https://t.co/OHLe52aKCb
May 8th 2019, 9:05am
TheTradeXchange @TheTradeXchange
$CYTR: CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain Cancer
May 8th 2019, 9:05am
TickerReport @TickerReport
CytRx $CYTR Sees Unusually-High Trading Volume https://t.co/72ghUAHJug
May 7th 2019, 8:05pm
buysellshort @buysellshort
$NURO low float patent win 82c, $CYTR giant flaot ran 25% today
May 7th 2019, 12:05pm
buysellshort @buysellshort
@PeteStock11 $NURO patent win 80c chart could run hard after $CYTR patent run Transcutaneous electrical nerve stim… https://t.co/JRevoWtKjr
May 7th 2019, 12:05pm
TopStockAlerts1 @TopStockAlerts1
$CYTR Moving on news
May 7th 2019, 11:05am
Ultra_Calls @Ultra_Calls
$CYTR Holding in full. Nothing is moving. Maybe this one goes. Need .62 / .64 breaks. Nice title on the patent news. Published May 7, 2019
May 7th 2019, 11:05am
Ultra_Calls @Ultra_Calls
$CYTR needs .62 .64 break now... Maybe this will run like our $DRRX Alert ?
May 7th 2019, 11:05am
MeeTrades @MeeTrades
chased some $CYTR at 0.59
May 7th 2019, 11:05am
tribehandler @tribehandler
RT @BioRunUp: $CYTR getting some volume on this USPTO patent granted today for "Cytotoxic agents for the treatment of cancer" https://t.co…
May 7th 2019, 11:05am
StockAuthority @StockAuthority
$CYTR nice keeps getting more buys here
May 7th 2019, 11:05am
BioRunUp @BioRunUp
$CYTR getting some volume on this USPTO patent granted today for "Cytotoxic agents for the treatment of cancer" https://t.co/Y1EHzGbRQY
May 7th 2019, 11:05am
Ultra_Calls @Ultra_Calls
$CYTR Should fly on this sexy patent. Trading under cash.
May 7th 2019, 11:05am
StockAuthority @StockAuthority
$CYTR has patent news, big one in terms of treating cancer, could run big IMO https://t.co/7WVe0TgtCw
May 7th 2019, 11:05am
Ultra_Calls @Ultra_Calls
$CYTR Patent News! Just out! Added .53 and .54 Cytotoxic agents for the treatment of cancer https://t.co/xUpY9dICRp
May 7th 2019, 11:05am
FinZTribune @FinZTribune
Comparison of Achieve Life Sciences Inc. $CYTR https://t.co/Zqom59zq8g
May 6th 2019, 9:05pm
FinZTribune @FinZTribune
Reviewing ANI Pharmaceuticals Inc. $CYTR's results https://t.co/S235n3l8YU
May 4th 2019, 9:05pm
OpenOutcrier @OpenOutcrier
$CYTR (+1.9% pre) CytRx Corporation Highlights Arimoclomol Clinical Milestone Guidance Provided by Licensee Orphazy… https://t.co/TYIuh22MXi
May 2nd 2019, 9:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.